Navigation Links
BioAnalytics Group CEO, Senior Scientist to Present at Tucson Symposium March 12-13
Date:3/11/2008

TUCSON, Ariz., March 11 /PRNewswire/ -- Scott Lett, CEO of The BioAnalytics Group LLC and Ned Haubein, Senior Scientist, will make scientific presentations at the Tucson Symposium on March 12-13, 2008. The symposium, subtitled, "Driving Pathology Forward in Drug Discovery, Development and Clinical Diagnostics," will be attended by hundreds of scientists and executives from the pharmaceutical, biotechnology and medical device industries.

Dr. Lett's invited presentation will focus on developing new tissue and cell-based assays based upon quantum dots-fluorescent nanocrystals used in digital microscopy.

"Quantum dot diagnostic and theranostic assays are moving forward to clinical applications," says Dr. Lett. "The presentations will share some of the lessons we have learned working with Ventana Medical Systems (VMSI) to develop new assays and analytics techniques over several years. Since this is all work in progress, we hope the presentation will prompt lively discussion."

The BioAnalytics Group has collaborated with Ventana Medical Systems since 2004, primarily developing tools and methodologies for utilizing quantum dots in digital pathology.

Dr. Haubein will present a poster on using web technologies to accelerate assay development. "Data management is a huge challenge," says Dr. Haubein. "With a perfect filing system, we'd have no trouble finding the data needed to support our decisions and conclusions. Unfortunately, today many scientists store their data in spreadsheets on their hard drives. Even with most data management systems, finding exactly the right data is like looking for a needle in a haystack."

In 2007, The BioAnalytics Group released BioPathwise DM(TM), a software- based product that provides researcher-friendly data management. "Web search engines have been helping us find needles for years," says Dr. Haubein, "and we're now applying them to the research laboratory in novel ways, further helping scientists to future-proof their data."

The BioAnalytics Group LLC, (Jamesburg, NJ) offers software and services in assay data analysis, data management, biological modeling, technology evaluation, intellectual property evaluation and custom software development. Customers include wet-lab and computational biology researchers in pharmaceutical, laboratory device, medical device companies, and academic research groups.

Products include BioPathwise 2.0, the pathway centric modeling and simulation system for biomedical researchers, and BioPathwise DM, researcher- friendly data management for capturing, sharing, searching and publishing laboratory-generated data, documents, images, spreadsheets, and the metadata that makes them meaningful.

http://www.bioanalyticsgroup.com


'/>"/>
SOURCE The BioAnalytics Group LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Avicena Group to Present at Noble Financial Conference
2. Chrome Group to Seek Listing for Some of its Subsidiaries
3. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
4. Reed Group to Provide MDA Internet Disability Duration Guidelines to U.S. Navy
5. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
6. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
8. ThirdBiotech Networking Group Launches
9. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
10. Reed Group Ltd. Announces Enterprise License for New Zealands Accident Compensation Corporation
11. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... the trading session at 4,833.32, down 0.22%; the Dow Jones ... the S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ... BIND Therapeutics Inc. (NASDAQ: BIND ). Learn more ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, ... tools designed, tuned and optimized exclusively for Okuma CNC machining centers at The ... of a collaboration among several companies with expertise in toolholding, cutting tools, machining ...
(Date:6/22/2016)... , June 22, 2016 Cell Applications, ... allow them to produce up to one billion ... lot within one week. These high-quality, consistent stem ... preparing cells and spend more time doing meaningful, ... a proprietary, high-volume manufacturing process that produces affordable, ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:5/24/2016)... IRVINE, Calif. , May 24, 2016 Ampronix facilitates superior patient care ... LMD3251MT  3D medical LCD display is the latest premium product recently added to ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):